Brand name: Omnipaque-180
Omnipaque-180 is a medicine containing the active ingredient(s) iohexol. On this page you will find out more about Omnipaque-180, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: iohexol
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Omnipaque-180 388 mg (iodine 180 mg)/mL injection solution, 20 x 20 mL vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS AS AT 12 NOVEMBER 2003: Intravascular: OMNIPAQUE is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. In children, OMNIPAQUE is indicated for angiography and urography. Oral/Body Cavities: OMNIPAQUE is indicated in adults for arthrography, endoscopic retrograde pancreatography (ERP), endoscopic retrograde cholangiopancreatography (ERCP), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.
Table of characteristics
| Active ingredient | |
|---|---|
| Visual appearance | Clear, colourless to pale yellow slightly viscous liquid |
| Dosage Form | Injection, solution |
| Route of administration | Intrathecal |
| Medicine schedule |
20mLx20: Not scheduled. Not considered by committee
|
There is one type of pack available.
Pack type 1
| Type | Vial |
|---|---|
| Storage temperature | Store below 30 degrees Celsius |
| Storage conditions | Protect from Light,Do not Freeze |
| Life time | 3 Years |
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Need more information?
These trusted information partners have more on this topic.
Found 2 results
Omnipaque (Intrathecal) 240 Solution for injection - myDr.com.au
Omnipaque (Intrathecal) 240 Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Omnipaque (Intravascular, Oral and Body Cavities) 240 Solution for injection - myDr.com.au
Omnipaque (Intravascular, Oral and Body Cavities) 240 Solution for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Found 0 results
